Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Neurology · Atypical Progressive Supranuclear Palsy

Biology and Subtypes: The Spectrum of Atypical PSP

At a Glance

Progressive Supranuclear Palsy (PSP) is a spectrum of brain disorders driven by the clumping of tau protein. While classic PSP primarily affects balance and eye movement, atypical variants cause unique early symptoms like tremors, gait freezing, or speech issues depending on where tau builds up.

While Progressive Supranuclear Palsy (PSP) is often discussed as a single disease, it is more accurately described as a spectrum of conditions [1]. What links every person on this spectrum is a specific biological process involving a protein called tau.

The Biology: Understanding “4R-Tauopathy”

Inside every healthy brain cell, a protein called tau acts like railroad ties, keeping the internal transport tracks of the cell straight and functional. In PSP, this protein becomes “misfolded”—it loses its shape and begins to clump together [2].

Specifically, PSP is classified as a 4-repeat (4R) tauopathy [3].

  • What is 4R? Tau comes in different “isoforms” or versions. In PSP, the brain produces too much of the “4-repeat” version, which is more prone to clumping [4].
  • The Damage: As these clumps (tangles) grow, they block the cell’s ability to move nutrients and energy [5]. This eventually leads to cell death.
  • Location Matters: The symptoms a person experiences depend entirely on where these 4R-tau clumps are building up [6].

The Classic Form: Richardson’s Syndrome (PSP-RS)

In the classic form, tau buildup is concentrated in deep, “subcortical” structures like the midbrain and brainstem [7]. Because these areas control balance and eye movement, patients typically experience early falls, a “stiff” or upright posture, and difficulty looking up or down [8].

The Atypical Spectrum

When tau accumulates in different patterns or locations—such as the cortex (the outer layer of the brain)—atypical variants emerge. Some of these versions progress more slowly than the classic form, while others can be equally aggressive [9][10].

PSP-Parkinsonism (PSP-P)

This is the most common atypical variant. It often looks like Parkinson’s disease in its early stages and typically progresses slower than the classic form [11][12].

  • Symptoms: Slowness of movement, limb stiffness, and sometimes a tremor [13].
  • Key Difference: Unlike classic PSP, patients may find some relief from Parkinson’s medications like levodopa for a few years [13].

PSP-Progressive Gait Freezing (PSP-PGF)

In this variant, the tau pathology is very focused on the motor pathways that control walking [14]. It generally has a gradual timeline.

  • Symptoms: The primary symptom is “freezing” of gait—a sudden feeling that the feet are glued to the floor, especially when turning or walking through a doorway [14].
  • Key Difference: Balance and eye movements often remain stable for many years [14].

PSP-Corticobasal Syndrome (PSP-CBS)

This variant occurs when tau builds up heavily in the motor cortex, often more on one side of the brain than the other [10]. Note that this variant can be as aggressive as classic Richardson’s syndrome [15].

  • Symptoms: Extreme stiffness or “jerking” in one arm or leg, and sometimes “alien limb” phenomena (where the limb seems to move on its own) [16].
  • Key Difference: It is highly asymmetric, meaning it affects one side of the body much more than the other [16].

PSP-Speech/Language (PSP-SL)

When tau targets the language centers of the brain (usually in the left frontal lobe), speech becomes the primary challenge [17].

  • Symptoms: Speech becomes slow, effortful, and hesitant. It is not just slurring; it is a struggle to physically produce the words [17].
  • Key Difference: Memory and walking may be completely normal for several years after speech issues begin [17].

PSP-Frontal (PSP-F)

In this variant, tau accumulates in the frontal lobes, which control personality, planning, and social behavior [18]. Like CBS, this can have a fast disease course.

  • Symptoms: Changes in personality, loss of interest (apathy), and difficulty making decisions or following complex instructions [19].
  • Key Difference: It can be mistaken for frontotemporal dementia because the physical movement symptoms may not appear until later [10].

Summary of Subtype Differences

Variant Primary Brain Region Hallmark Sign
PSP-RS (Classic) Midbrain/Brainstem Early falls, eye movement issues [7]
PSP-P Subcortical Parkinson-like slowness and tremor [11]
PSP-PGF Brainstem/Motor Sudden gait freezing [14]
PSP-CBS Motor Cortex One-sided stiffness and jerking [10]
PSP-SL Language Centers Effortful, non-fluent speech [17]
PSP-F Frontal Lobes Personality and behavior changes [18]

Common questions in this guide

What does it mean that PSP is a 4R-tauopathy?
In PSP, the brain produces too much of a specific version of the tau protein called '4-repeat' or 4R. This protein loses its shape and clumps together, blocking brain cells from moving nutrients and energy, which eventually leads to cell death.
How is atypical PSP different from classic Richardson's Syndrome?
Classic PSP, known as Richardson's Syndrome, primarily affects balance and eye movement because tau builds up in the midbrain. Atypical PSP variants occur when tau builds up in other areas of the brain, leading to very different early symptoms like speech difficulty, sudden gait freezing, or Parkinson-like tremors.
Is there a type of PSP that looks like Parkinson's disease?
Yes, PSP-Parkinsonism (PSP-P) is the most common atypical variant and often looks like Parkinson's disease in its early stages. Patients experience slowness, stiffness, and tremors, and unlike classic PSP, they may get temporary relief from Parkinson's medications like levodopa.
Why do some people with PSP suddenly freeze while walking?
Sudden gait freezing—where your feet feel glued to the floor—is the hallmark symptom of PSP-Progressive Gait Freezing (PSP-PGF). In this variant, the damaging tau protein buildup is heavily concentrated in the specific motor pathways that control walking.
Can atypical PSP affect personality and behavior?
Yes. In the PSP-Frontal (PSP-F) variant, tau protein accumulates in the brain's frontal lobes. This leads to early personality changes, apathy, and difficulty making decisions, which can sometimes appear before any physical movement symptoms.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on the symptoms, which brain regions (cortical or subcortical) seem to be most affected by tau buildup?
  2. 2.Since the diagnosis is a variant like PSP-P, how does the treatment approach differ from someone with the classic Richardson's syndrome?
  3. 3.Are there specific imaging findings, like midbrain atrophy or frontal hypometabolism, that confirm this specific subtype?
  4. 4.How often should we re-evaluate the subtype, as I've heard symptoms can sometimes overlap or change over time?
  5. 5.Given the 4R-tau biology of this disease, are there any clinical trials specifically targeting tau protein that we should consider?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.

    Boxer AL, Yu JT, Golbe LI, et al.

    The Lancet. Neurology 2017; (16(7)):552-563 doi:10.1016/S1474-4422(17)30157-6.

    PMID: 28653647
  2. 2

    Motor and non-motor features in progressive supranuclear palsy: the impact of microtubule associated protein tau haplotypes among a Tunisian cohort.

    Abida Y, Sghaier I, Souissi A, et al.

    Journal of neural transmission (Vienna, Austria : 1996) 2026; (133(3)):423-432 doi:10.1007/s00702-025-03004-z.

    PMID: 40810960
  3. 3

    MAPT haplotype-associated transcriptomic changes in progressive supranuclear palsy.

    Ressler HW, Humphrey J, Vialle RA, et al.

    Acta neuropathologica communications 2024; (12(1)):135 doi:10.1186/s40478-024-01839-3.

    PMID: 39154163
  4. 4

    The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes.

    Buchholz S, Zempel H

    Alzheimer's & dementia : the journal of the Alzheimer's Association 2024; (20(5)):3606-3628 doi:10.1002/alz.13784.

    PMID: 38556838
  5. 5

    Tau-Mitochondria Interactions in Neurodegeneration: Mechanisms and Therapeutic Potential.

    Castillo-Casaña Y, Arias C, Coria R

    Cellular and molecular neurobiology 2025; (46(1)):3 doi:10.1007/s10571-025-01634-1.

    PMID: 41291371
  6. 6

    Histologic tau lesions and magnetic resonance imaging biomarkers differ across two progressive supranuclear palsy variants.

    Orlandi F, Carlos AF, Ali F, et al.

    Brain communications 2024; (6(2)):fcae113 doi:10.1093/braincomms/fcae113.

    PMID: 38660629
  7. 7

    18 F-FDG, 18 F-FP-CIT, and 18 F-Florzolotau PET Imaging in Progressive Supranuclear Palsy : Region-Specific Correlations Between Glucose Metabolism, Dopaminergic Function, and Tau Pathology.

    Liang M, Jia C, Huang Z, et al.

    Clinical nuclear medicine 2026; (51(3)):220-225 doi:10.1097/RLU.0000000000006254.

    PMID: 41474764
  8. 8

    Multimodal Magnetic Resonance Imaging Quantification of Brain Changes in Progressive Supranuclear Palsy.

    Pyatigorskaya N, Yahia-Cherif L, Gaurav R, et al.

    Movement disorders : official journal of the Movement Disorder Society 2020; (35(1)):161-170 doi:10.1002/mds.27877.

    PMID: 31710146
  9. 9

    Clinical progression of progressive supranuclear palsy: impact of trials bias and phenotype variants.

    Street D, Malpetti M, Rittman T, et al.

    Brain communications 2021; (3(3)):fcab206 doi:10.1093/braincomms/fcab206.

    PMID: 34541533
  10. 10

    Frontal hypometabolism in the diagnosis of progressive supranuclear palsy clinical variants.

    Black JA, Pham NTT, Ali F, et al.

    Journal of neurology 2024; (271(7)):4267-4280 doi:10.1007/s00415-024-12350-z.

    PMID: 38632125
  11. 11

    Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease.

    Quattrone A, Bianco MG, Antonini A, et al.

    Movement disorders : official journal of the Movement Disorder Society 2022; (37(6)):1272-1281 doi:10.1002/mds.28992.

    PMID: 35403258
  12. 12

    Subtypes of PSP and Prognosis: A Retrospective Analysis.

    Mahale RR, Krishnan S, Divya KP, et al.

    Annals of Indian Academy of Neurology 2021; (24(1)):56-62 doi:10.4103/aian.AIAN_611_20.

    PMID: 33911380
  13. 13

    Tau in Atypical Parkinsonisms: A Meta-Analysis of in Vivo PET Imaging Findings.

    Mena AM, Chen R, Graff-Guerrero A, et al.

    Movement disorders clinical practice 2023; (10(12)):1725-1737 doi:10.1002/mdc3.13885.

    PMID: 38094644
  14. 14

    Association of PSP phenotypes with survival: A brain-bank study.

    Guasp M, Molina-Porcel L, Painous C, et al.

    Parkinsonism & related disorders 2021; (84()):77-81 doi:10.1016/j.parkreldis.2021.01.015.

    PMID: 33581485
  15. 15

    Probable 4-Repeat Tauopathy Criteria Predict Brain Amyloid Negativity, Distinct Clinical Features, and FDG-PET/MRI Neurodegeneneration Patterns in Corticobasal Syndrome.

    Parmera JB, de Godoi Carneiro C, de Almeida IJ, et al.

    Movement disorders clinical practice 2024; (11(3)):238-247 doi:10.1002/mdc3.13959.

    PMID: 38155526
  16. 16

    An autopsy case of progressive supranuclear palsy with severe corticospinal tract degeneration.

    Kuru S, Sakai M, Moriyoshi H, et al.

    Neuropathology : official journal of the Japanese Society of Neuropathology 2024; (44(6)):452-458 doi:10.1111/neup.13001.

    PMID: 39180287
  17. 17

    An Evaluation of the Progressive Supranuclear Palsy Speech/Language Variant.

    Whitwell JL, Stevens CA, Duffy JR, et al.

    Movement disorders clinical practice 2019; (6(6)):452-461 doi:10.1002/mdc3.12796.

    PMID: 31392246
  18. 18

    Brainstem and cerebellar radiological findings in progressive supranuclear palsy.

    Spiegel C, Marotta C, Bertram K, et al.

    Brain communications 2025; (7(1)):fcaf051 doi:10.1093/braincomms/fcaf051.

    PMID: 39958262
  19. 19

    Depression and Apathy across Different Variants of Progressive Supranuclear Palsy.

    Bower SM, Weigand SD, Ali F, et al.

    Movement disorders clinical practice 2022; (9(2)):212-217 doi:10.1002/mdc3.13396.

    PMID: 35146060

This page explains atypical Progressive Supranuclear Palsy (PSP) variants for educational purposes only. Always consult a neurologist or movement disorder specialist for an accurate diagnosis and personalized treatment plan.

Get notified when new evidence is published on Atypical progressive supranuclear palsy syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.